| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5503068 | Journal of the Neurological Sciences | 2017 | 4 Pages |
Abstract
TNFα-I may play a role in the development of myelopathies in absence of brain involvement or other features of demyelinating disease. TNFα-I associated myelopathy should be considered in patients with history of treatment with TNFα-I who exhibit symptoms of myelopathy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Paula Barreras, Maureen A. Mealy, Carlos A. Pardo,